Form 6-K Abivax S.A. For: Dec 31
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of March 2026
Commission file number: 001-41842
Abivax SA
(Exact name of Registrant as specified in its charter and translation of Registrant’s name into English)
7-11 boulevard Haussmann
75009 Paris, France
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
On March 23, 2026, Abivax SA (the "Registrant") issued a press release announcing its full-year financial results as of December 31, 2025, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Exhibit Index | |||||
Exhibit 99.1 | |||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Abivax SA (Registrant) | ||||||||
| Date: March 23, 2026 | /s/ Marc de Garidel | |||||||
| Chief Executive Officer | ||||||||
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Nexa Initiative Launches to Support Climate and Health Innovations
- Growing Interest in Liver Wellness Leads Consumers to Explore PureHealth Research Liver Health Supplements
- Tec-Do 2.0 at 36Kr Waves: Nie Eileen on AI Investment First Principles
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
